Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional Accepts healthy volunteers

Effects of Different Instrument Assisted Soft Tissue Mobilization Force Applications on Ankle Stiffness and Dorsiflexion

ClinicalTrials.gov ID: NCT07927179

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07927179. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Different IASTM Force Applications on Ankle Stiffness and Dorsiflexion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Instrument-assisted soft tissue mobilization (IASTM) is a technique commonly used in sports medicine to reduce muscle tightness and improve range of motion. The technique involves using a handheld instrument, typically made of metal, to apply pressure and massage soft tissues. The instrument allows clinicians to target specific areas while reducing stress on their hands. Previous research has demonstrated that IASTM may improve range of motion and reduce muscle tightness. However, little is known about how the amount of force applied during treatment influences these outcomes. This study aims to investigate the effects of different IASTM treatment forces on calf muscle stiffness and ankle dorsiflexion (the movement of the foot upward toward the shin). Participants will receive either low-force IASTM (0-5 N), high-force IASTM (10-15 N), or no treatment depending on what group they are assigned to. Treatment force will be monitored using a sensor attached to the IASTM instrument (Figure 1). Changes in tissue stiffness will be assessed using the MyotonPRO, a handheld device that measures the mechanical properties of muscles and other soft tissues. Changes in ankle dorsiflexion will be evaluated using clinical movement tests and motion capture analysis. The findings may help researchers and clinicians better understand how different IASTM treatment protocols influence tissue stiffness and ankle mobility, potentially contributing to more standardized treatment recommendations.

Study identification

NCT ID
NCT07927179
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of Idaho
Other
Enrollment
45 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 39 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2026 (Estimated)
Primary completion
Dec 1, 2027 (Estimated)
Completion
Jan 2028 (Estimated)
Last update posted
Nov 10, 2026

2026 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Integrated Sports Medicine and Movement Analysis Laboratory Moscow Idaho 83843 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07927179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 10, 2026 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.